Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 7, Number 5, October 2017, pages 153-158


The Prevalence of Resistant Hypertension Among Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology, and Genetics

Table

Table 1. Distribution of Resistant Hypertension by Certain Clinical Data and Laboratory Variables Using Chi-Square Test (N = 880)
 
CharacteristicsResistant hypertension (N = 141)Non-resistant hypertension (n = 739)P value
N (%)*%**N (%)*%**
BMI0.014
  Normal4 (7)2.853 (93)7.2
  Overweight30 (12.3)21.3214 (87.7)29
  Obese107 (18.5)75.9472 (81.5)63.8
DM duration0.000
  < 5 years17 (8.9)12.1174 (91.1)23.5
  5 - 9 years28 (12.3)19.9199 (87.7)26.9
  > 10 years96 (20.8)68.1366 (79.2)49.5
Hypertension duration0.000
  < 5 years7 (2.6)5258 (97.4)34.9
  5 - 9 years29 (14.8)20.6167 (85.2)22.6
  > 10 years105 (25.1)74.5314 (74.9)42.5
HbA1c0.200
  Controlled A1C < 738 (13.6)27242 (86.4)67.3
  Uncontrolled A1C ≥ 7103 (17.2)73497 (82.8)32.7
Hypertension controlling0.000
  Controlled BP30 (7.8)21.3355 (92.2)48
  Uncontrolled BP111 (22.4)78.7384 (77.6)52
Dyslipidemia0.002
  Yes132 (17.5)93.6632 (82.5)93.6
  No9 (7.2)6.4116 (92.8)6.4
Retinopathy0.004
  Yes36 (24.3)25.5112 (75.7)15.2
  No105 (14.3)74.5627 (85.7)84.8
CVD0.000
  Yes77 (30.2)54.6178 (69.8)75.9
  No64 (10.2)45.4561 (89.8)24.1
DM medication0.001
OHA48 (11.3)43377 (88.7)51
Insulin only8 (23.5)5.726 (76.5)3.5
Both83 (20.2)60.3336 (79.8)45.5
GFR0.025
  > 90111 (19.5)84.7458 (80.5)72.6
  90 - 6013 (9.2)9.9128 (90.8)20.3
  59 - 306 (12.5)4.642 (87.5)6.7
29 - 151 (25)0.83 (75)0.5